Showing results (81-90 of 224) with videos related to

Sort By:
Pageof 23
Open Heart|February 13, 2016
Pentoxifylline for vascular health: a brief review of the literatureMark F McCarty, James H O'Keefe, James J DiNicolantonio
Open Heart|November 10, 2017
Added fructose as a principal driver of non-alcoholic fatty liver disease: a public health crisisJames J DiNicolantonio, Ashwin M Subramonian, James H O'Keefe
Open Heart|December 15, 2022
Nutraceutical activation of Sirt1: a reviewJames J DiNicolantonio, Mark F McCarty, James H O'Keefe
British Journal of Sports Medicine|August 25, 2017
Sugar addiction: is it real? A narrative reviewJames J DiNicolantonio, James H O'Keefe, William L Wilson
Cardiology|September 6, 2012
Mortality in the TRACER and ATLAS ACS 2 trials: two more reasons to audit vital records in PLATOVictor L Serebruany, James J DiNicolantonio, Mehmet Mustafa Can
Journal of Dietary Supplements|April 19, 2018
Glucosamine for the Treatment of Osteoarthritis: The Time Has Come for Higher-Dose TrialsMark F McCarty, James H O'Keefe, James J DiNicolantonio
The American Journal of Cardiology|January 14, 2017
Statins, Ezetimibe, and Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors to Reduce Low-Density Lipoprotein Cholesterol and Cardiovascular EventsJames H O'Keefe, James J DiNicolantonio, Carl J Lavie
Postgraduate Medicine|August 13, 2013
Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindoprilJames J Dinicolantonio, Carl J Lavie, James H O'Keefe
Immunology Letters|October 1, 2020
Azithromycin and glucosamine may amplify the type 1 interferon response to RNA viruses in a complementary fashionJames J DiNicolantonio, Jorge Barroso-Aranda, Mark F McCarty
Pageof 23